Huang Y - Search Results

1

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials.

Hong S, Fang W, Liang W, Yan Y, Zhou T, Qin T, Wu X, Ma Y, Zhao Y, Yang Y, Hu Z, Xue C, Hou X, Chen Y, Huang Y, Zhao H, Zhang L. Hong S, et al. Among authors: huang y. Onco Targets Ther. 2014 Oct 7;7:1851-67. doi: 10.2147/OTT.S68386. eCollection 2014. Onco Targets Ther. 2014. Retraction in: Onco Targets Ther. 2016 Oct 20;9:6377. doi: 10.2147/OTT.S124095. PMID: 25336977 Free PMC article. Retracted.

2

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Fu XH, et al. Among authors: huang hq, huang y. Ai Zheng. 2006 Aug;25(8):1013-8. Ai Zheng. 2006. PMID: 16965685 Chinese.

3

Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.

Zhao YY, Xue C, Hou X, Liao H, Li S, Zhao HY, Huang Y, Chen LK, Xu F, Liu JL, Zhang L. Zhao YY, et al. Among authors: huang y. Eur J Cancer. 2011 Apr;47(6):848-53. doi: 10.1016/j.ejca.2010.12.004. Epub 2011 Jan 20. Eur J Cancer. 2011. PMID: 21256000 Clinical Trial.

4

Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.

Zhao YY, Xue C, Jiang W, Zhao HY, Huang Y, Feenstra K, Resau JH, Qian CN, Zhang L. Zhao YY, et al. Among authors: huang y. J Thorac Oncol. 2012 Jan;7(1):71-5. doi: 10.1097/JTO.0b013e31823085f4. J Thorac Oncol. 2012. PMID: 22011670 Free article.

5

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.

Zhao HY, Huang H, Hu ZH, Huang Y, Lin SX, Tian Y, Lin TY. Zhao HY, et al. Among authors: huang h, huang y. Anticancer Drugs. 2012 Jun;23(5):534-42. doi: 10.1097/CAD.0b013e32834f7ef4. Anticancer Drugs. 2012. PMID: 22481060

6

National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China.

Xue C, Hu Z, Jiang W, Zhao Y, Xu F, Huang Y, Zhao H, Wu J, Zhang Y, Zhao L, Zhang J, Chen L, Zhang L. Xue C, et al. Among authors: huang y. Lung Cancer. 2012 Aug;77(2):371-5. doi: 10.1016/j.lungcan.2012.04.014. Epub 2012 May 10. Lung Cancer. 2012. PMID: 22579298

7

Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma.

Zhao LP, Xue C, Zhang JW, Hu ZH, Zhao YY, Zhang J, Huang Y, Zhao HY, Zhang L. Zhao LP, et al. Among authors: huang y. Chin J Cancer. 2012 Oct;31(10):476-83. doi: 10.5732/cjc.012.10029. Epub 2012 Jun 6. Chin J Cancer. 2012. PMID: 22692073 Free PMC article.

8

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.

Zhang Y, Zhao L, Huang P, Wu J, Wang F, Huang Y, Zhang L. Zhang Y, et al. Among authors: huang p, huang y. Cancer Chemother Pharmacol. 2012 Oct;70(4):611-5. doi: 10.1007/s00280-012-1950-7. Epub 2012 Aug 19. Cancer Chemother Pharmacol. 2012. PMID: 22903536 Clinical Trial.

9

[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].

Huang Y, Liu Y, Zhou J, Xu N, Li B, Wu G, Fang J, Li K, Liu X, Liu W, Lu Y, Wang M, Liu W, Liang H, Zhang Y, Huang C, Wang S, Wang Y, Yu S, Chang J, Wang Z, Hu Z, Zhang L. Huang Y, et al. Among authors: huang c. Zhongguo Fei Ai Za Zhi. 2012 Oct;15(10):576-82. doi: 10.3779/j.issn.1009-3419.2012.10.03. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23075681 Free PMC article. Clinical Trial. Chinese.

10

SPARC expression and prognostic value in non-small cell lung cancer.

Huang Y, Zhang J, Zhao YY, Jiang W, Xue C, Xu F, Zhao HY, Zhang Y, Zhao LP, Hu ZH, Yao ZW, Liu QY, Zhang L. Huang Y, et al. Chin J Cancer. 2012 Nov;31(11):541-8. doi: 10.5732/cjc.012.10212. Epub 2012 Oct 10. Chin J Cancer. 2012. PMID: 23114088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80,688 results

Search Page

Filters